受强制性开放获取政策约束的文章 - Dongqing Yan, Ph.D.了解详情
可在其他位置公开访问的文章：21 篇
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease
H Akada, D Yan, H Zou, S Fiering, RE Hutchison, MG Mohi
Blood, The Journal of the American Society of Hematology 115 (17), 3589-3597, 2010
强制性开放获取政策： US National Institutes of Health
Combining the allosteric inhibitor asciminib with ponatinib suppresses emergence of and restores efficacy against highly resistant BCR-ABL1 mutants
CA Eide, MS Zabriskie, SLS Stevens, O Antelope, NA Vellore, H Than, ...
Cancer Cell 36 (4), 431-443. e5, 2019
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs, Howard …
Age-related mutations and chronic myelomonocytic leukemia
CC Mason, JS Khorashad, SK Tantravahi, TW Kelley, MS Zabriskie, ...
Leukemia 30 (4), 906-913, 2016
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Critical requirement for Stat5 in a mouse model of polycythemia vera
D Yan, RE Hutchison, G Mohi
Blood, The Journal of the American Society of Hematology 119 (15), 3539-3549, 2012
强制性开放获取政策： US National Institutes of Health
The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations
A Franzini, AD Pomicter, D Yan, JS Khorashad, SK Tantravahi, H Than, ...
Blood Advances 3 (20), 2949-2961, 2019
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
SIRT5 is a druggable metabolic vulnerability in acute myeloid leukemia
D Yan, A Franzini, AD Pomicter, BJ Halverson, O Antelope, CC Mason, ...
Blood cancer discovery 2 (3), 266-287, 2021
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Differential biological activity of disease-associated JAK2 mutants
H Zou, D Yan, G Mohi
FEBS letters 585 (7), 1007-1013, 2011
强制性开放获取政策： US National Institutes of Health
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera
AB Patel, A Franzini, E Leroy, SJ Kim, AD Pomicter, L Genet, M Xiao, ...
Blood, The Journal of the American Society of Hematology 134 (26), 2388-2398, 2019
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Nuclear–cytoplasmic transport is a therapeutic target in myelofibrosis
D Yan, AD Pomicter, S Tantravahi, CC Mason, AV Senina, JM Ahmann, ...
Clinical Cancer Research 25 (7), 2323-2335, 2019
强制性开放获取政策： US National Institutes of Health
STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in mice
A Dutta, D Yan, RE Hutchison, G Mohi
British journal of haematology 180 (6), 911, 2018
强制性开放获取政策： US National Institutes of Health
Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in mice
D Yan, F Jobe, RE Hutchison, G Mohi
Leukemia 29 (10), 2050-2061, 2015
强制性开放获取政策： US National Institutes of Health
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis
H Zhao, AD Pomicter, AM Eiring, A Franzini, J Ahmann, JY Hwang, ...
Blood, The Journal of the American Society of Hematology 139 (5), 761-778, 2022
强制性开放获取政策： US National Institutes of Health
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms
AB Patel, AD Pomicter, D Yan, AM Eiring, O Antelope, JA Schumacher, ...
Leukemia 34 (11), 2981-2991, 2020
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia
MS Zabriskie, CA Eide, D Yan, NA Vellore, AD Pomicter, SL Savage, ...
Leukemia 30 (6), 1418-1421, 2016
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice
D Yan, RE Hutchison, G Mohi
Blood, The Journal of the American Society of Hematology 120 (9), 1888-1898, 2012
强制性开放获取政策： US National Institutes of Health
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells
H Than, AD Pomicter, D Yan, LP Beaver, AM Eiring, WL Heaton, A Senina, ...
Leukemia 34 (6), 1679-1683, 2020
强制性开放获取政策： US National Institutes of Health, National Medical Research Council, Singapore
Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective
H Than, Y Qiao, X Huang, D Yan, JS Khorashad, AD Pomicter, ...
Leukemia 32 (9), 2049-2054, 2018
强制性开放获取政策： US National Institutes of Health, National Medical Research Council …
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism
MA Gonzalez, IM Olivas, AE Bencomo‐Alvarez, AJ Rubio, ...
Clinical and Translational Medicine 12 (12), e1146, 2022
强制性开放获取政策： US National Institutes of Health, National Institute for Health Research, UK
ddeeper Than Deep: Can ddPCR Predict Successful Imatinib Cessation?
DMW Yan D, Pomicter AD, O'Hare T
Clin Cancer Res., 2019
强制性开放获取政策： US National Institutes of Health
Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy
JS Khorashad, SK Tantravahi, D Yan, CC Mason, Y Qiao, AM Eiring, ...
Leukemia 30 (11), 2275-2279, 2016
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
出版信息和资助信息由计算机程序自动确定